Ranibizumab intravítreo en neovascularización coroidea secundaria a distrofia foveomacular viteliforme del adulto / Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy
Arch. Soc. Esp. Oftalmol
; 87(5): 149-152, mayo 2012. ilus
Article
in Spanish
| IBECS
| ID: ibc-99393
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Caso clínico Varón de 70 años diagnosticado de distrofia foveomacular viteliforme del adulto(DFVA) que en el curso de su enfermedad presenta disminución brusca de visión en el ojo izquierdo coincidiendo con la aparición de una membrana neovascular oculta. Dada la localización yuxtafove al de la membrana, se decidió tratar con ranibizumab intravítreo, siendo necesarias 2 inyecciones para lograr el cierre completo de la lesión neovascular. Discusión:
El uso de ranibizumab intravítreo puede ser una opción de tratamiento eficaz en la neovascularización coroidea secundaria a DFVA, y se precisan series de casos más amplias para poder confirmar esta observación(AU)ABSTRACT
Case report A 70-year-old male patient diagnosed with bilateral adult-onset vitelliform dystrophy presented with a sudden decrease of vision in his left eye associated with the appearance of an occult type of neovascular membrane. It was treated with intravitreal ranibizumab due to juxtafoveal location of the membrane. Two injections were needed to induce total regression of the lesion. Discussion:
Intravitreal ranibizumab may be effective to induce morphological and functional improvement in cases of choroidal neovascularization secondary to adult-onset vitelliform foveomacular dystrophy. Further case series are required to confirm this observation(AU)
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Choroidal Neovascularization
/
Vitelliform Macular Dystrophy
/
Antibodies, Monoclonal
Type of study:
Risk factors
Limits:
Aged
/
Humans
/
Male
Language:
Spanish
Journal:
Arch. Soc. Esp. Oftalmol
Year:
2012
Document type:
Article
Institution/Affiliation country:
Hospital Universitario Miguel Servet/España